Qi Xue Kang oral liquid for prolonged menstruation or hypomenorrhea with qi deficiency and blood stasis syndrome

Phase 4, randomised, double-blind trial of Qi Xue Kang in menstrual disorders, hypermenorrhea and hypomenorrhea (2 arms), sponsored by Capital Medical University. Primary endpoints: Change in menstrual period length from baseline and Change in menstrual volume from baseline after treatment. Planned start Jun 2018; status: not yet recruiting.